M A R Hadjzadeh1,2, V Alikhani1, S Hosseinian1,3, B Zarei1, Z Keshavarzi4. 1. Mashhad University of Medical Sciences, School of Medicine, Department of physiology, Bojnurd, Iran. 2. Mashhad University of Medical Sciences, Psychiatry and Behavioral Sciences Research Center, Division of Neurocognitive Sciences, Bojnurd, Iran. 3. Mashhad University of Medical Sciences, Neurogenic Inflammation Research Center, Mashhad, Bojnurd, Iran. 4. Mashhad University of Medical Sciences, North Khorasan University of Medical Sciences, Natural Products and Medicinal Plants Research Center, Bojnurd, Iran.
Abstract
OBJECTIVE: The aim of this study was to evaluate the possible protective effects of MT against gastric oxidative stress and dyslipidemia in streptozotocin (STZ) - induced diabetic rats. METHODS: Forty male Wistar rats were randomly divided into five groups: control, diabetic, MT 5 mg/kg+ STZ, MT 10 mg/kg+ STZ and MT 20 mg/kg+ STZ. STZ (60 mg/kg) was intraperitoneally (ip) injected as a single dose for diabetes induction. One week after STZ administration, MT was injected daily as ip for 14 days. The levels of malondialdehyde (MDA), total thiol and glutathione, as well as superoxide dismutase (SOD) and catalase activities were measured in gastric tissue. Serum concentrations of triglycerides (TG), total cholesterol (TC), high density lipoprotein (HDL) and low density lipoprotein (LDL) were also determined. RESULTS: Serum glucose significantly increased in diabetic group compared to control group. STZ induced a significant decrease in gastric tissue levels of total thiol, glutathione, catalase and SOD activities and a significant increase in MDA concentration. In diabetic rats, serum TG, LDL and TC were significantly higher and HDL was significantly lower than in the control group. Treatment of diabetic rats with MT caused a significant increase in gastric total thiol content and glutathione concentration as well as SOD and catalase activities. Gastric MDA concentration and serum LDL, TG and TC were significantly lower in MT-treated groups when compared with diabetic group. CONCLUSION: These data suggested that MT has a therapeutic effect on gastric oxidative damage and dyslipidemia induced by diabetes that possibly may be due to its antioxidant effects.
OBJECTIVE: The aim of this study was to evaluate the possible protective effects of MT against gastric oxidative stress and dyslipidemia in streptozotocin (STZ) - induced diabetic rats. METHODS: Forty male Wistar rats were randomly divided into five groups: control, diabetic, MT 5 mg/kg+ STZ, MT 10 mg/kg+ STZ and MT 20 mg/kg+ STZ. STZ (60 mg/kg) was intraperitoneally (ip) injected as a single dose for diabetes induction. One week after STZ administration, MT was injected daily as ip for 14 days. The levels of malondialdehyde (MDA), total thiol and glutathione, as well as superoxide dismutase (SOD) and catalase activities were measured in gastric tissue. Serum concentrations of triglycerides (TG), total cholesterol (TC), high density lipoprotein (HDL) and low density lipoprotein (LDL) were also determined. RESULTS: Serum glucose significantly increased in diabetic group compared to control group. STZ induced a significant decrease in gastric tissue levels of total thiol, glutathione, catalase and SOD activities and a significant increase in MDA concentration. In diabetic rats, serum TG, LDL and TC were significantly higher and HDL was significantly lower than in the control group. Treatment of diabetic rats with MT caused a significant increase in gastric total thiol content and glutathione concentration as well as SOD and catalase activities. Gastric MDA concentration and serum LDL, TG and TC were significantly lower in MT-treated groups when compared with diabetic group. CONCLUSION: These data suggested that MT has a therapeutic effect on gastric oxidative damage and dyslipidemia induced by diabetes that possibly may be due to its antioxidant effects.
Authors: T Wolden-Hanson; D R Mitton; R L McCants; S M Yellon; C W Wilkinson; A M Matsumoto; D D Rasmussen Journal: Endocrinology Date: 2000-02 Impact factor: 4.736
Authors: Peter Bytzer; Nicholas J Talley; Johann Hammer; Lisa J Young; Michael P Jones; Michael Horowitz Journal: Am J Gastroenterol Date: 2002-03 Impact factor: 10.864
Authors: D X Tan; L C Manchester; R J Reiter; B F Plummer; J Limson; S T Weintraub; W Qi Journal: Free Radic Biol Med Date: 2000-12 Impact factor: 7.376
Authors: Talita da Silva Mendes de Farias; Regislane Ino da Paixao; Maysa Mariana Cruz; Roberta Dourado Cavalcante da Cunha de Sa; Jussara de Jesus Simão; Vitor Jaco Antraco; Maria Isabel Cardoso Alonso-Vale Journal: Cells Date: 2019-09-06 Impact factor: 6.600